LCM Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
9,707
+56
| +0.6% | +$6.21K | 0.56% | 33 |
|
|
2025
Q1 | $1.08M | Buy |
9,651
+224
| +2% | +$25.1K | 0.64% | 30 |
|
|
2024
Q4 | $871K | Buy |
9,427
+31
| +0.3% | +$2.86K | 0.49% | 39 |
|
|
2024
Q3 | $788K | Buy |
9,396
+206
| +2% | +$17.3K | 0.45% | 40 |
|
|
2024
Q2 | $631K | Buy |
9,190
+237
| +3% | +$16.3K | 0.39% | 41 |
|
|
2024
Q1 | $656K | Buy |
8,953
+19
| +0.2% | +$1.39K | 0.42% | 42 |
|
|
2023
Q4 | $724K | Buy |
8,934
+23
| +0.3% | +$1.86K | 0.52% | 34 |
|
|
2023
Q3 | $668K | Buy |
8,911
+412
| +5% | +$30.9K | 0.54% | 33 |
|
|
2023
Q2 | $655K | Buy |
8,499
+113
| +1% | +$8.71K | 0.53% | 35 |
|
|
2023
Q1 | $696K | Buy |
8,386
+451
| +6% | +$37.4K | 0.61% | 33 |
|
|
2022
Q4 | $681K | Buy |
7,935
+5
| +0.1% | +$429 | 0.66% | 30 |
|
|
2022
Q3 | $489K | Sell |
7,930
-32
| -0.4% | -$1.97K | 0.52% | 35 |
|
|
2022
Q2 | $492K | Sell |
7,962
-2
| -0% | -$124 | 0.48% | 40 |
|
|
2022
Q1 | $473K | Buy |
7,964
+330
| +4% | +$19.6K | 0.38% | 47 |
|
|
2021
Q4 | $554K | Buy |
7,634
+317
| +4% | +$23K | 0.43% | 44 |
|
|
2021
Q3 | $511K | Buy |
7,317
+18
| +0.2% | +$1.26K | 0.43% | 46 |
|
|
2021
Q2 | $503K | Sell |
7,299
-134
| -2% | -$9.23K | 0.42% | 45 |
|
|
2021
Q1 | $480K | Sell |
7,433
-272
| -4% | -$17.6K | 0.43% | 46 |
|
|
2020
Q4 | $449K | Buy |
+7,705
| New | +$449K | 0.43% | 43 |
|